Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trimetazidine SR in Post-PCI Angina Prevention
CTR20150353Phase 3Completed
- Sponsor
- Servier
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trimetazidine in angina pectoris, coronary arteriosclerosis, sponsored by Servier. Started Jul 2018; status: completed.
02
Drugs
trimetazidine
03
Conditions
angina pectoriscoronary arteriosclerosis
Beyond the preview
Go deeper on CTR20150353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150353.